References
Bishop HM, Blarney RW. A suggested classification of breast pain. Postgraduate Medical Journal 55 (Suppl. 5): 59–60, 1979
Bradbeer JW, Kyngdon J. Primary treatment of breast cancer in the elderly women with tamoxifen. Clinical Oncology 9: 31–34, 1983
Cole MP, Jones CTA, Todd IDH. A new anti-oestrogenic agent in late breast cancer: an early appraisal of ICI 146474. British Journal of Cancer 25: 270–275, 1971
Eggert-Kruse W, Von Furrier D, Legier U, Junkermann H. Comparison of danazol with tamoxifen, gestagen, acupuncture, local treatment and placebo. Results in 1000 atients. In Baum et al. (Eds) Benign breast disease, Royal Society of Medicine, London, 1985
Emmens CW. Post-coital contraception. British Medical Bulletin 26: 45–51, 1970
Fentiman IS, Caleffi M, Brame K, Chaudary MA, Hayward JL. Double-blind controlled trial of tamoxifen therapy for mastalgia. Lancet 1: 287–288, 1986
Fex G, Adielsson G, Mattson W. Oestrogen-like effects of tamoxifen on the concentration of proteins in the plasma. Acta Endocrinologica (Copenhagen) 97: 109–113, 1981
Gorins A, Perrett F, Tournaut B, Rogier C, Lipszc J. A French double-blind cross-over study (danazol versus placebo) in the treatment of severe fibrocystic breast disease. European Journal of Gynaecological Oncology 2: 85–89, 1984
Gotfredson A, Christiansen C, Palshof T. The effect of tamoxifen on bone mineral content in premenopausal women with breast cancer. Cancer 53: 853–857, 1984
Jordan VC, Fritz NF, van Beuden M. Prophylactic tamoxifen. Lancet 1: 910, 1986
Lipton A, Harvey HA, Hamilton RW. Venous thrombosis as a side effect of tamoxifen treatment. Cancer Treatment Reports 68: 887–889, 1984
Lunan CB, Green B. 3H-oestradiol uptake in vivo by human uterine endometrium: effect of tamoxifen, ICI 46474. Clinical Endocrinology 3: 465–480, 1974
Mansel RE, Preece PE, Hughes LE. A double-blind trial of the prolactin inhibitor bromocriptine in painful breast disease. British Journal of Surgery 65: 724–727, 1978
Mansel RE, Wisbey JR, Hughes LE. Controlled trial of the antigonadotropin danazol in painful nodular benign breast disease. Lancet 1: 928–930, 1982
Nichols S, Watson WE, Wheeler MJ. The management of female breast disease by Southampton general practitioners. British Medical Journal 281: 1450–1453, 1980
Preece PE, Mansel RE, Bolton PM, Hughes LE, Baum M, et al. Clinical syndromes of mastalgia. Lancet 2: 670–673, 1976
Preece PE, Baum M, Mansel RE, Webster DJT, Fortt RW, et al. Importance of mastalgia in operable breast cancer. British Medical Journal 284: 1299–1300, 1982
Rose C, Thorpe S, Anderson KW, Pedersen BV, Mouridsen HT, et al. Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values. Lancet 1: 16–19, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fentiman, I.S. Tamoxifen and Mastalgia. Drugs 32, 477–480 (1986). https://doi.org/10.2165/00003495-198632060-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198632060-00001